Literature DB >> 19484240

Disturbance of the gut-associated lymphoid tissue is associated with disease progression in chronic HIV infection.

Ursula Hofer1, Roberto F Speck.   

Abstract

Why and how HIV makes people sick is highly debated. Recent evidence implicates heightened immune activation due to breakdown of the gastrointestinal barrier as a determining factor of lentiviral pathogenesis. HIV-mediated loss of Th17 cells from the gut-associated lymphoid tissue (GALT) impairs mucosal integrity and innate defense mechanisms against gut microbes. Translocation of microbial products from the gut, in turn, correlates with increased immune activation in chronic HIV infection and may further damage the immune system by increasing viral and activation-induced T cell death, by reducing T cell reconstitution due to tissue scarring, and by impairing the function of other cell types, such as gammadelta T cells and epithelial cells. Maintaining a healthy GALT may be the key to reducing the pathogenic potential of HIV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19484240     DOI: 10.1007/s00281-009-0158-3

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  58 in total

Review 1.  Regulatory pathways governing HIV-1 replication.

Authors:  B R Cullen; W C Greene
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

2.  Lymphatic tissue fibrosis is associated with reduced numbers of naive CD4+ T cells in human immunodeficiency virus type 1 infection.

Authors:  Timothy W Schacker; Jason M Brenchley; Gregory J Beilman; Cavan Reilly; Stefan E Pambuccian; Jodie Taylor; David Skarda; Matthew Larson; Daniel C Douek; Ashley T Haase
Journal:  Clin Vaccine Immunol       Date:  2006-05

3.  Ablation of thymic export causes accelerated decay of naive CD4 T cells in the periphery because of activation by environmental antigen.

Authors:  Christine Bourgeois; Zhenyue Hao; Klaus Rajewsky; Alexandre J Potocnik; Brigitta Stockinger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-18       Impact factor: 11.205

4.  Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients.

Authors:  H-J Epple; T Schneider; H Troeger; D Kunkel; K Allers; V Moos; M Amasheh; C Loddenkemper; M Fromm; M Zeitz; J-D Schulzke
Journal:  Gut       Date:  2008-10-20       Impact factor: 23.059

5.  Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence.

Authors:  Ivona V Pandrea; Rajeev Gautam; Ruy M Ribeiro; Jason M Brenchley; Isolde F Butler; Melissa Pattison; Terri Rasmussen; Preston A Marx; Guido Silvestri; Andrew A Lackner; Alan S Perelson; Daniel C Douek; Ronald S Veazey; Cristian Apetrei
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

6.  Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients.

Authors:  Emmanouil Papasavvas; Maxwell Pistilli; Griffin Reynolds; Robert Bucki; Livio Azzoni; Jihed Chehimi; Paul A Janmey; Mark J DiNubile; Joe Ondercin; Jay R Kostman; Karam C Mounzer; Luis J Montaner
Journal:  AIDS       Date:  2009-01-28       Impact factor: 4.177

7.  Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis.

Authors:  Timothy W Schacker; Phuong L Nguyen; Gregory J Beilman; Steven Wolinsky; Matthew Larson; Cavan Reilly; Ashley T Haase
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

8.  Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection.

Authors:  Valentina Cecchinato; Elzbieta Tryniszewska; Zhong Min Ma; Monica Vaccari; Adriano Boasso; Wen-Po Tsai; Constantinos Petrovas; Dietmar Fuchs; Jean-Michel Heraud; David Venzon; Gene M Shearer; Richard A Koup; Israel Lowy; Christopher J Miller; Genoveffa Franchini
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

9.  Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense.

Authors:  P Ye; F H Rodriguez; S Kanaly; K L Stocking; J Schurr; P Schwarzenberger; P Oliver; W Huang; P Zhang; J Zhang; J E Shellito; G J Bagby; S Nelson; K Charrier; J J Peschon; J K Kolls
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

10.  Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients.

Authors:  Petronela Ancuta; Anupa Kamat; Kevin J Kunstman; Eun-Young Kim; Patrick Autissier; Alysse Wurcel; Tauheed Zaman; David Stone; Megan Mefford; Susan Morgello; Elyse J Singer; Steven M Wolinsky; Dana Gabuzda
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

View more
  23 in total

1.  Collection, isolation, and flow cytometric analysis of human endocervical samples.

Authors:  Jennifer A Juno; Genevieve Boily-Larouche; Julie Lajoie; Keith R Fowke
Journal:  J Vis Exp       Date:  2014-07-06       Impact factor: 1.355

2.  Retinoic acid imprints a mucosal-like phenotype on dendritic cells with an increased ability to fuel HIV-1 infection.

Authors:  Natalia Guerra-Pérez; Ines Frank; Filippo Veglia; Meropi Aravantinou; Diana Goode; James L Blanchard; Agegnehu Gettie; Melissa Robbiani; Elena Martinelli
Journal:  J Immunol       Date:  2015-01-26       Impact factor: 5.422

3.  Parallel studies of mucosal immunity in the reproductive and gastrointestinal mucosa of HIV-infected women.

Authors:  Uma Shanmugasundaram; J William Critchfield; Linda C Giudice; Karen Smith-McCune; Ruth M Greenblatt; Barbara L Shacklett
Journal:  Am J Reprod Immunol       Date:  2020-05-08       Impact factor: 3.886

4.  Protective effects of terminal ileostomy against bacterial translocation in a rat model of intestinal ischemia/reperfusion injury.

Authors:  Zhi-Liang Lin; Wen-Kui Yu; Shan-Jun Tan; Kai-Peng Duan; Yi Dong; Xiao-Wu Bai; Lin Xu; Ning Li
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

5.  Inadequate clearance of translocated bacterial products in HIV-infected humanized mice.

Authors:  Ursula Hofer; Erika Schlaepfer; Stefan Baenziger; Marc Nischang; Stephan Regenass; Reto Schwendener; Werner Kempf; David Nadal; Roberto F Speck
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

6.  Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.

Authors:  Anupa Kamat; Petronela Ancuta; Richard S Blumberg; Dana Gabuzda
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

Review 7.  Microbial translocation in HIV infection: causes, consequences and treatment opportunities.

Authors:  Netanya G Sandler; Daniel C Douek
Journal:  Nat Rev Microbiol       Date:  2012-08-13       Impact factor: 60.633

8.  Triggering TLR2, -3, -4, -5, and -8 reinforces the restrictive nature of M1- and M2-polarized macrophages to HIV.

Authors:  Erika Schlaepfer; Mary-Aude Rochat; Li Duo; Roberto F Speck
Journal:  J Virol       Date:  2014-06-18       Impact factor: 5.103

9.  Tissue-specific HIV-1 infection: why it matters.

Authors:  Maile Ay Karris; Davey M Smith
Journal:  Future Virol       Date:  2011-07       Impact factor: 1.831

10.  Dietary input of microbes and host genetic variation shape among-population differences in stickleback gut microbiota.

Authors:  Chris C R Smith; Lisa K Snowberg; J Gregory Caporaso; Rob Knight; Daniel I Bolnick
Journal:  ISME J       Date:  2015-04-24       Impact factor: 10.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.